Reading Time: 2 minutes ImpriMed, a Silicon Valley-based AI precision medicine company, has raised KRW 30 billion in Series A funding. The round was led by SoftBank Ventures, with participation from Han River Partners, SK Telecom, KDB Silicon Valley, Ignite Innovation Fund, Samyang Chemical Group, Murex Partners, and Byuksan. The company’s total cumulative investment now stands at KRW 45 … ImpriMed, a Silicon Valley-based AI precision medicine company, raises KRW 30 billion in Series A funding 계속 읽기